Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

4,259 studies for “Alzheimer disease”

Early Diagnosis of SCD Based on RadiogenomicsCompleted
NCT04696315N/AUpdated Aug 21, 2026
Sponsor: Ying Han
Alzheimer Disease · Subjective Cognitive Decline · Neuroimaging · Gene
China
Caring Recharge Project for Caregivers of Individuals With Alzheimer's DiseaseRecruiting
NCT07764185Phase 2Updated Aug 21, 2026
Sponsor: Photozig, Inc.
Caregiver Stress
United States
Effects and Mechanisms of Temporal Interference Brain Stimulation on Memory Function in Preclinical Alzheimer's DiseaseRecruiting
NCT07031687NAUpdated Aug 21, 2026
Sponsor: Xuanwu Hospital, Beijing
Alzheimer Disease
China
PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI)Recruiting
NCT07169630Phase 1Updated Aug 21, 2026
Sponsor: National Institute of Mental Health (NIMH)
Alzheimer s Disease · Mild Cognitive Impairment · Healthy
United States
Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory LossCompleted
NCT02008357Phase 3Updated Aug 21, 2026
Sponsor: Eli Lilly and Company
Cognition Disorders
United States, Australia, Canada, Japan
Amyloid PET Imaging in the Baltimore Longitudinal Study of AgingRecruiting
NCT07099053N/AUpdated Aug 21, 2026
Sponsor: National Institute on Aging (NIA)
Aging
United States
A Study to Evaluate the Drug Levels, Absolute Bioavailability, Safety, Tolerability, and Immunogenicity of Single-Dose of BMS-986446 in Healthy Adults After Single-dose Administration, and Participants With Early Alzheimer's Disease After Multiple Dose AdministrationNot Yet Recruiting
NCT07780383Phase 1Updated Aug 21, 2026
Sponsor: Bristol-Myers Squibb
Alzheimer's Disease · Healthy Participants
United States
Causal Effect of Coenzyme Q10 Nutrition and Cognitive Dysfunction in the Metabolic Storm (Hyperglycemia and Sarcopenia) and Brain-derived Neurotrophic FactorCompleted
NCT06040905NAUpdated Aug 21, 2026
Sponsor: Chung Shan Medical University
Mild Cognitive Impairment · Alzheimer Disease · Hyperglycemia · Pre-sarcopenia
Taiwan
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease StudiesRecruiting
NCT07177352Phase 3Updated Aug 21, 2026
Sponsor: Hoffmann-La Roche
Alzheimers Disease
United States, Argentina, Australia, Brazil, Canada +9 more
Efficacy of RGn600 in Patients With Mild-to-moderate Alzheimer's DiseaseRecruiting
NCT05926011NAUpdated Aug 21, 2026
Sponsor: REGEnLIFE SAS
Alzheimer Disease
France
VICA: A Virtual Care Assistant for Dementia CaregiversNot Yet Recruiting
NCT07779785NAUpdated Aug 21, 2026
Sponsor: Indiana University
Alzheimer Dementia (AD) · Caregiver Burden of People With Dementia
United States
Acupressure as Long-term Intervention to Slow the Progression of Early/Mild Alzheimer's DiseaseNot Yet Recruiting
NCT07779863NAUpdated Aug 21, 2026
Sponsor: The University of Hong Kong
Alzheimer's Disease
Hong Kong
InRAD Observational StudyRecruiting
NCT07213700N/AUpdated Aug 21, 2026
Sponsor: Stichting International Registry for Alzheimer's Disease and other Dementias Foundation
Alzheimer's Disease(AD) · Mild Cognitive Impairment (MCI) · Subjective Cognitive Decline (SCD) · Non-Alzheimer Degenerative Dementia
Austria, Belgium, Brazil, Czechia, Greece +4 more
Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's DiseaseRecruiting
NCT06847321Phase 2Updated Aug 21, 2026
Sponsor: Lighthouse Pharmaceuticals, Inc.
Alzheimer Disease · Alzheimer Disease Due to P. Gingivalis
United States
AV-1980R (Tau Vaccine) in Preclinical Alzheimer's Disease (TAURUS-1980)Recruiting
NCT07158905Phase 1Updated Aug 21, 2026
Sponsor: Institute for Molecular Medicine
Alzheimer Disease · Preclinical Alzheimer's Disease
United States
Physical Activity, Alzheimer's Disease and Cognition Relative to APOE GenotypeCompleted
NCT03876314NAUpdated Aug 21, 2026
Sponsor: University of North Carolina, Greensboro
Healthy · Dementia · Alzheimer Disease · Physical Activity
United States
Effect of Equol Supplementation on Arterial Stiffness and Cognition in Healthy VolunteersActive Not Recruiting
NCT05741060Phase 2Updated Aug 20, 2026
Sponsor: Akira Sekikawa
Arterial Stiffness · White Matter Lesions · Cognitive Decline
United States
Inherited Diseases, Caregiving, and Social NetworksCompleted
NCT01498263N/AUpdated Aug 20, 2026
Sponsor: National Human Genome Research Institute (NHGRI)
Undiagnosed Disease · Healthy Volunteer (Adult With Typically Developing Child) · Inherited Neurodegenerative Disorders · Inherited Metabolic Disorders (Inborn Errors of Metabolism)
United States
Central Auditory Processing Modulation Underlying Anxiety Reduction Using Clinically Designed Improvisatory MusicRecruiting
NCT07775625NAUpdated Aug 20, 2026
Sponsor: Northwestern University
Alzheimer's Disease
United States
Fisetin in Mild Alzheimer's DiseaseCompleted
NCT07279714Phase 2Updated Aug 20, 2026
Sponsor: Sunnybrook Health Sciences Centre
Alzheimer s Disease · Alzheimer Dementia · Alzheimer Dementia (AD) · Alzheimer Disease
Canada
A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of DNL921 in Healthy Participants and Participants With Alzheimer's DiseaseRecruiting
NCT07758595Phase 1Updated Aug 20, 2026
Sponsor: Denali Therapeutics Inc.
Alzheimer's Disease · Healthy Participants
United Kingdom
Enhancing Shared Decision-making to Guide Care for People With Dementia and DiabetesRecruiting
NCT05643144NAUpdated Aug 20, 2026
Sponsor: Indiana University
Diabetes · Alzheimer's Disease (Incl Subtypes) · Dementia · Hypoglycemia
United States
ENhancing Outcomes in Cognitive Impairment Through Use of Home Sleep ApNea TestingRecruiting
NCT04335994NAUpdated Aug 20, 2026
Sponsor: Sunnybrook Health Sciences Centre
Obstructive Sleep Apnea · Alzheimer Disease · Vascular Dementia · Mild Cognitive Impairment
Canada
N-AD: Orally Administered Nicotinamide Riboside Over Two Years as a Potential Disease Modifying Treatment for Alzheimer's DiseaseRecruiting
NCT07741071Phase 2Updated Aug 20, 2026
Sponsor: Haukeland University Hospital
Alzheimer Disease (AD)
Norway
Aging and Exercise Impacts on Glymphatic FunctionNot Yet Recruiting
NCT07775196NAUpdated Aug 20, 2026
Sponsor: University of Texas Southwestern Medical Center
Aging and Exercise Impacts on Glymphatic Function

4,259 studies found